Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

Hims & Hers Health announced today that it has entered into “a long-term collaboration” with Danish drugmaker Novo Nordisk to offer its popular weight-loss drug Wegovy to its users through the ...

Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is ...

The ad then promoted Hims & Hers' weight loss products ... companies took a hit when the Food and Drug Administration (FDA) announced that semaglutide was no longer in short supply, making ...

That partnership will see Hims & Hers offer Novo Nordisk’s weight-loss drug Wegovy ... a compounded semaglutide due to a semaglutide shortage. But once the U.S. Food and Drug Administration ...

Hims & Hers started prescribing compounded semaglutide, the active ingredient in Novo Nordisk's diabetes drug Ozempic and Wegovy, in May of 2024. The company has largely had to stop offering the ...

Novo Nordisk on Tuesday said it will offer its weight loss drug ... Hims & Hers started prescribing compounded semaglutide, the active ingredient in Novo Nordisk's diabetes drug Ozempic and ...